학술논문
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Document Type
Article
Author
Shinde, Vivek ; Cho, Iksung; Plested, Joyce S; Agrawal, Sapeckshita; Fiske, Jamie; Cai, Rongman; Zhou, Haixia; Pham, Xuan; Zhu, Mingzhu; Cloney-Clark, Shane; Wang, Nan; Zhou, Bin; Lewis, Maggie; Price-Abbott, Patty; Patel, Nita; Massare, Michael J; Smith, Gale; Keech, Cheryl; Fries, Louis; Glenn, Gregory M
Source
In The Lancet Infectious Diseases January 2022 22(1):73-84
Subject
Language
ISSN
1473-3099